These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6040403)
1. The metabolism of mescaline-14-C in rats. Musacchio JM; Goldstein M Biochem Pharmacol; 1967 Jun; 16(6):963-70. PubMed ID: 6040403 [No Abstract] [Full Text] [Related]
2. Study with mescaline-8-C14 in mice: effect of amine oxidase inhibitors on metabolism. Shah NS; Himwich HE Neuropharmacology; 1971 Sep; 10(5):547-56. PubMed ID: 5126692 [No Abstract] [Full Text] [Related]
3. A comparative study on the metabolism of 3,4-dimethoxyphenylethylamine-C 14 and mescaline-C 14 by rabbit, mouse and rat brain homogenates. Shah NS Arch Int Pharmacodyn Ther; 1971 Oct; 193(2):357-61. PubMed ID: 5119220 [No Abstract] [Full Text] [Related]
4. Comparison of metabolism of mescaline and 3,4-dimethoxyphenylethylamine in humans. Charalampous KD Behav Neuropsychiatry; 1971; 2(11):26-9 passim. PubMed ID: 5566331 [No Abstract] [Full Text] [Related]
5. Beta-hydroxylation of N-acetyl-3,4-dimethoxyphenethylamine and the influence of iproniazid on the demethylation of this compound in vivo in the rat. Van Winkle E; Schweitzer JW; Friedhoff AJ Biochem Pharmacol; 1970 Jun; 19(6):2137-44. PubMed ID: 5513979 [No Abstract] [Full Text] [Related]
6. A comparative study of mescaline and 3,4-dimethoxy-phenylethylamine in isolated brain mitochondria and brain homogenate. Shah NS; Himwich HE Brain Res; 1971 Nov; 34(1):163-70. PubMed ID: 5124914 [No Abstract] [Full Text] [Related]
8. The roles of 3,4,5-trihydroxy-beta-phenethylamine and 3,4-dimethoxy-beta-phenethylamine in the biosynthesis of Mescaline. Paul AG; Rosenberg H; Khanna KL Lloydia; 1969 Mar; 32(1):36-9. PubMed ID: 5788765 [No Abstract] [Full Text] [Related]
9. [Oxidative degradation of mescaline in the central nervous system. I. Properties of the mescaline-degrading enzyme]. Seiler N Hoppe Seylers Z Physiol Chem; 1965; 341(1):105-10. PubMed ID: 5896221 [No Abstract] [Full Text] [Related]
10. Effects of chlorpromazine and haloperidol on the disposition of mescaline-14C in mice. Shah NS; Shah KR; Lawrence RS; Neely AE J Pharmacol Exp Ther; 1973 Aug; 186(2):297-304. PubMed ID: 4719782 [No Abstract] [Full Text] [Related]
12. Subcellular distribution of 8- 14 C-mescaline in the mouse brain and liver. Shah NS Biochem Pharmacol; 1971 Nov; 20(11):3207-10. PubMed ID: 5132121 [No Abstract] [Full Text] [Related]
14. Alteration by pretreatment with iproniazid and an inactive mescaline analogue of a behaviour change induced by mescaline. Smythies JR; Johnston VS; Bradley RJ Nature; 1967 Oct; 216(5111):196-7. PubMed ID: 6057240 [No Abstract] [Full Text] [Related]
15. Schizophrenia and pink spot. Stam FC; Heslinga FJ; van Tilburg W Psychiatr Neurol Neurochir; 1969; 72(6):513-24. PubMed ID: 5369242 [No Abstract] [Full Text] [Related]
16. Placental transfer and tissue distribution of mescaline- 14 C in the mouse. Shah NS; Neely AE; Shah KR; Lawrence RS J Pharmacol Exp Ther; 1973 Feb; 184(2):489-93. PubMed ID: 4688184 [No Abstract] [Full Text] [Related]
17. Biosynthetic studies on mescaline and related cactus alkaloids. Lundström J Acta Pharm Suec; 1971 Jun; 8(3):275-302. PubMed ID: 5560272 [No Abstract] [Full Text] [Related]
18. Discriminative stimulus properties of mescaline: mescaline or metabolite? Browne RG; Ho BT Pharmacol Biochem Behav; 1975; 3(1):109-14. PubMed ID: 1129346 [TBL] [Abstract][Full Text] [Related]
19. Peripheral tissue distribution, brain distribution, metabolism, placental transfer, & fetal distribution of mescaline- 14 C in monkeys. Taska RJ Tex Med; 1972 Sep; 68(9):56-67. PubMed ID: 4627169 [No Abstract] [Full Text] [Related]
20. The metabolic alteration of drugs. Schreiber EC Annu Rev Pharmacol; 1970; 10():77-98. PubMed ID: 4392814 [No Abstract] [Full Text] [Related] [Next] [New Search]